Business Description
Shelter Pharma Ltd
SIC : 2834
ISIN : INE013V01011
Total Employee Number:
69Compare
Compare
Traded in other countries / regions
543963.India IPO Date
2023-08-23Description
Shelter Pharma Ltd is an Indian pharmaceutical company that manufactures herbal and botanical-based medicines for both human and veterinary use. Its product portfolio spans tablets, syrups, baby drops, barley water, oils, powders, and ointments, covering many non-critical therapeutic segments. The company serves customers across India through distributors, wholesalers, and retail pharmacies, with a focus on herbal and Ayurvedic formulations. It operates primarily in the domestic Indian market, where demand for traditional and plant-based remedies is significant. Revenue is generated through the sale of finished pharmaceutical and herbal products to healthcare distributors and institutions. The company maintains manufacturing facilities in India and markets its products under its own brands. Its dual focus on human and animal health distinguishes it within the herbal medicine segment.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.35 | |||||
Equity-to-Asset | 0.91 | |||||
Debt-to-Equity | 0.01 | |||||
Debt-to-EBITDA | 0.06 | |||||
Interest Coverage | 114.46 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 6.57 | |||||
Beneish M-Score | -0.85 | |||||
WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 10.3 | |||||
3-Year EBITDA Growth Rate | 5.6 | |||||
3-Year EPS without NRI Growth Rate | 0.2 | |||||
3-Year FCF Growth Rate | -112.8 | |||||
3-Year Book Growth Rate | 54.2 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.87 | |||||
9-Day RSI | 66.66 | |||||
14-Day RSI | 65.15 | |||||
3-1 Month Momentum % | -5.24 | |||||
6-1 Month Momentum % | -14.64 | |||||
12-1 Month Momentum % | -36.12 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 7.86 | |||||
Quick Ratio | 4.37 | |||||
Cash Ratio | 0.15 | |||||
Days Inventory | 118.4 | |||||
Days Sales Outstanding | 53.6 | |||||
Days Payable | 7.22 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Dividend Yield % | 0.97 | |||||
Dividend Payout Ratio | 0.07 | |||||
Forward Dividend Yield % | 0.97 | |||||
5-Year Yield-on-Cost % | 0.97 | |||||
3-Year Average Share Buyback Ratio | -12.8 | |||||
Shareholder Yield % | -47.51 |
Profitability Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 24.01 | |||||
Operating Margin % | 16.84 | |||||
Net Margin % | 12.34 | |||||
EBITDA Margin % | 17.42 | |||||
FCF Margin % | -19.24 | |||||
OCF Margin % | -17.06 | |||||
ROE % | 15.04 | |||||
ROA % | 13.58 | |||||
ROIC % | 14.64 | |||||
3-Year ROIIC % | 5.28 | |||||
ROC (Joel Greenblatt) % | 31.8 | |||||
ROCE % | 20.27 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PE Ratio | 7.36 | |||||
PE Ratio without NRI | 7.36 | |||||
PS Ratio | 0.69 | |||||
PB Ratio | 0.78 | |||||
Price-to-Tangible-Book | 0.77 | |||||
EV-to-EBIT | 4.89 | |||||
EV-to-EBITDA | 4.74 | |||||
EV-to-Revenue | 0.83 | |||||
EV-to-FCF | -3.67 | |||||
Price-to-GF-Value | 0.6 | |||||
Price-to-Graham-Number | 0.49 | |||||
| Price-to-Net-Current-Asset-Value | 1.23 | |||||
Earnings Yield (Greenblatt) % | 20.46 | |||||
FCF Yield % | -23.22 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shelter Pharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ₹) | 731.336 | ||
| EPS (TTM) (₹) | 4.89 | ||
| Beta | 0.592 | ||
| 3-Year Sharpe Ratio | -0.07 | ||
| 3-Year Sortino Ratio | -0.12 | ||
| Volatility % | 43.64 | ||
| 14-Day RSI | 65.15 | ||
| 14-Day ATR (₹) | 1.926068 | ||
| 20-Day SMA (₹) | 32.612 | ||
| 12-1 Month Momentum % | -36.12 | ||
| 52-Week Range (₹) | 23 - 46.51 | ||
| Shares Outstanding (Mil) | 16.84 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shelter Pharma Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shelter Pharma Ltd Stock Events
| Event | Date | Price (₹) | ||
|---|---|---|---|---|
| INR 0.350000 Cash Dividend | 2025-09-23 | 43.27 (+0.86%) | ||
| INR 0.330000 Cash Dividend | 2024-09-23 | 48.21 (+2.57%) |
Show
Entries
Shelter Pharma Ltd Frequently Asked Questions
What is Shelter Pharma Ltd(BOM:543963)'s stock price today?
The current price of BOM:543963 is ₹35.13. The 52 week high of BOM:543963 is ₹46.51 and 52 week low is ₹23.00.
When is next earnings date of Shelter Pharma Ltd(BOM:543963)?
The next earnings date of Shelter Pharma Ltd(BOM:543963) is .
Does Shelter Pharma Ltd(BOM:543963) pay dividends? If so, how much?
The Dividend Yield %  of Shelter Pharma Ltd(BOM:543963) is 0.97% (As of Today), Highest Dividend Payout Ratio of Shelter Pharma Ltd(BOM:543963) was 0.07. The lowest was 0.05. And the median was 0.06. The  Forward Dividend Yield % of Shelter Pharma Ltd(BOM:543963) is 0.97%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers